Kidney toxicity is a common side effect of some chemotherapy drugs such as cisplatin (Platinol), doxorubicin (Adriamycin), and oxaliplatin (Eloxatin) (Lahoti 2012
Cui Z, Zhang J, Zhang J, Zhong J, Wu J, Miao Y, et al
Phase III Complete the maturation of the companys technology developed in Phase II to TRL 6/7 and produce prototypes to support further development and commercialization
BPC-157 is explicitly named on the WADA Prohibited List (Section S0) since 2022
Key Ingredients BPC-157 BPC-157 supports cellular repair and tissue regeneration pathways
To endow particles with a targeted recognition capability, CD5 antibodies were added to LNPs via SATA-maleimide chemistry to minimize T-cell depletion by CD5 compared with other antibodies (Fig